NeuroRx solidifies Intellectual Property Position - receives notice of Allowance by US Patent Office
Company with research operations in US and Israel seeks to develop first-in-class drug to decrease the risk of suicide in those suffering from depression
Sunday, October 16, 2016 (1:55pm)
NeuroRx solidifies Intellectual Property Position - receives notice of Allowance by US Patent Office
